BB - VC Deals: Goldman Backs Chinese Research Data Security
Welcome to Seeking Alpha’s Venture Capital Deals of the Week. Follow this account and turn on the e-mail alert to receive VCDeals in your inbox on Friday afternoons.
- Goldman Sachs (GS) led the $62M Series D for Fountain Medical, a Chinese contract research organization for pharmaceuticals. Lilly Asia Ventures also participated. The startup’s global team covers 55 cities in China and delivery centers in several nations, including the U.S. and Japan. Fountain specializes in clinical development, biostatistics, and regulatory affairs.
- Samsung ([[SSNNF]],[[SSNLF]]) and Mubadala co-led the $55M Series B for quantum computing startup IonQ, which